Under the agreement, Cabot will license intellectual property rights to XG's xGnP® graphene nanoplatelets technology, including detailed know-how regarding the manufacturing process.

Graphenes are highly electrically and thermally conductive, mechanically strong, thin sheets of carbon atoms. They are used as performance-enhancing materials in composites to add strength, stability, electrical and thermal conductivity and other properties at lower loading levels than traditional materials.

Cabot Corporation, headquartered in Boston, Massachusetts, USA, is a speciality chemicals and performance materials company. Its products include carbon black, fumed silica, inkjet colorants, aerogel, capacitor materials, and cesium formate drilling fluids.

"Graphenes have the potential to be a dramatic step forward for our customers as they strive to find ways to make parts lighter, stronger or store energy more effectively," says Fred von Gottberg, Cabot vice president, New Business segment.

"Our expertise in carbon black production, surface treatment and material science makes us a natural fit for delivering performance in automotive plastics, electronics packaging, advanced batteries and other applications with graphenes."

XG Sciences, located in East Lansing, Michigan, develops and sells xGnP graphenes into a number of applications.